Novel antibiotic succeeds in trial against hospital-acquired pneumonia
A Rutgers researcher leading a trial found that the novel combination antibiotic sulbactam-durlobactam combats dangerous pneumonia at least as well as the best currently approved treatment.
May 16, 2023
0
50